Education
About Us
Working with TipRanks
Follow Us
Journey Medical Corp (DERM)
NASDAQ:DERM
Total Valuation
Journey Medical Corp has a market cap or net worth of $172.16M. The enterprise value is $176.25M.
Market Cap$172.16M
Enterprise Value$176.25M
Share Statistics
Journey Medical Corp has 17,295,769 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,295,769
Owned by Insiders43.85%
Owned by Institutions18.31%
Financial Efficiency
Journey Medical Corp’s return on equity (ROE) is -0.73 and return on invested capital (ROIC) is -29.95%.
Return on Equity (ROE)-0.73
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-29.95%
Return on Capital Employed (ROCE)-0.30
Revenue Per Employee1.37M
Profits Per Employee-357.85K
Employee Count41
Asset Turnover0.70
Inventory Turnover1.45
Valuation Ratios
The current PE Ratio of Journey Medical Corp is -5.44. Journey Medical Corp’s PEG ratio is -0.43.
PE Ratio-5.44
PS Ratio0.00
PB Ratio7.76
Price to Fair Value3.98
Price to FCF-7.85
Price to Operating Cash Flow-24.08
PEG Ratio-0.43
Income Statement
In the last 12 months, Journey Medical Corp had revenue of 56.13M and earned -14.67M in profits. Earnings per share was -0.72.
Revenue56.13M
Gross Profit35.26M
Operating Income-13.68M
Pretax Income-14.61M
Net Income-14.67M
EBITDA-8.40M
Earnings Per Share (EPS)-0.72
Cash Flow
In the last 12 months, operating cash flow was -6.94M and capital expenditures 0.00, giving a free cash flow of -21.94M billion.
Operating Cash Flow-6.94M
Free Cash Flow-21.94M
Free Cash Flow per Share-1.27
Dividends & Yields
Journey Medical Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.17
52-Week Price Change26.06%
50-Day Moving Average6.90
200-Day Moving Average5.59
Relative Strength Index (RSI)49.64
Average Volume (3m)100.03K
Important Dates
Journey Medical Corp upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
Journey Medical Corp as a current ratio of 1.37, with Debt / Equity ratio of 116.83%
Current Ratio1.37
Quick Ratio0.96
Debt to Market Cap0.32
Net Debt to EBITDA-0.57
Interest Coverage Ratio-5.07
Taxes
In the past 12 months, Journey Medical Corp has paid 61.00K in taxes.
Income Tax61.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Journey Medical Corp EV to EBITDA ratio is -10.08, with an EV/FCF ratio of -9.28.
EV to Sales1.51
EV to EBITDA-10.08
EV to Free Cash Flow-9.28
EV to Operating Cash Flow-9.28
Balance Sheet
Journey Medical Corp has $21.07M in cash and marketable securities with $25.17M in debt, giving a net cash position of $4.10M billion.
Cash & Marketable Securities$21.07M
Total Debt$25.17M
Net Cash$4.10M
Net Cash Per Share$0.24
Tangible Book Value Per Share-$0.58
Margins
Gross margin is 66.48%, with operating margin of -24.36%, and net profit margin of -26.14%.
Gross Margin66.48%
Operating Margin-24.36%
Pretax Margin-26.03%
Net Profit Margin-26.14%
EBITDA Margin-14.96%
EBIT Margin-21.22%
Analyst Forecast
The average price target for Journey Medical Corp is $9.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$9.33
Price Target Upside30.31% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-29.69%
EPS Growth Forecast-105.88%